Research Grant
[Cite as http://purl.org/au-research/grants/nhmrc/1026880]Researchers: A/Pr Brian Oliver (Principal investigator)
Brief description Airway fibrosis or scaring causes significant morbidity in both chronic obstructive pulmonary disease (COPD) and asthma . These diseases affect 10-15% of the population, and cost the health system $1.15 billion per year. Airway fibrosis is not decreased by the current therapeutics used to treat COPD and asthma, and as such there is a pressing need to develop therapeutics to specifically treat airway fibrosis. Dr Brian Oliver has partnered with Pharmaxis to develop new therapeutics to specifically treat fibrosis
Funding Amount $AUD 422,685.45
Funding Scheme Career Development Fellowships
Notes Industry CDF
- PURL : http://purl.org/au-research/grants/nhmrc/1026880
- nhmrc : 1026880